**13. References**


receptor-alpha in a rodent experimental stroke model. *Stroke,* Vol.36, No.2, (February 2005), pp. 337-341, ISSN 0039-2499

Angiogenesis and the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease 105

DiSalvo, J., Bayne, M.L.,Conn, G., Kwok, P.W., Trivedi, P.G., Soderman, D.D., Palisi, T.M.,

Dumont, D.J., Fong, G.H., Puri, M.C., Gradwohl, G., Alitalo, K. & Breitman, M.L. (1995)

Ecder, T., Fick-Brosnahan, G.M. & Schrier, R.W. (2007) Polycystic kidney disease, In: *Diseases* 

Ettinger, A, Khahn, P.C. & Wise, H.M. (1969) The importance of selective renal angiography

European Polycystic Kidney Disease Consortium. (1994). The polycystic kidney disease gene

Fabris, L., Cadamuro, M., Fiorotto, R., Roskams, T., Spirli, C., Melero, S., Sonzogni, A.,

Fiedler, U. & Augustin HG. (2006) Angiopoietins: a link between angiogenesis and

Folkman, J. Tumor angiogenesis: therapeutic implications. (1971) *N Engl J Med*.,Vol.285, No.

Freedman, B.I., Soucie, J.M., Chapman, A., Krisher, J. & McClellan, W.M. (2000). Racial

Futrakul, N., Butthep, P. & Futrakul, P. (2008) Altered vascular homeostasis in chronic

Gabow, P.A., Johnson, A,M., Kaehny, W.D., Kimberling, W.J., Lezotte, D.C., Duley, I.T. &

Grantham, J.J & Calvet J.P. (2001) Polycystic kidney disease: In danger of being X-rated?

Guo, Q., Carrero,J.J., Yu, X., Bárány, P., Qureshi, A.R., Eriksson, M., Anderstam, B.,

*Hepatology*, Vol.43, No.5, (May 2006), pp. 1001-1012, ISSN 1386-6346 Fick-Brosnahan, G,M,, Tran, Z.V., Johnson, A.M., Strain, J.D.& Gabow, P.A. (2001)

*Int.,* Vol.59, No.5, (May 2001), pp. 1654-1662, ISSN 0085-2538

21, (November 1971), pp. 1182-1186, ISSN 0028-4793 Folkman, J. (2006) Angiogenesis. *Ann Rev Med.*,Vol. 57, 1-18, ISSN 0066-4219

35, No.1, (January 2000) , pp. 35-39, ISSN 0272-6386

Wilkins, ISBN 13:978-0-7817-9307-0, Philadelphia, PA., USA

No.1, (May 1995), pp. 80-92, ISSN 1058-8388

pp. 156-161, ISSN 0970-1591

*Cell*, 77, pp. 881-894, ISSN 0092-8674

9258

0972-4567

(online) 1386-0291

1311-1319, ISSN 0085-2538

Sullivan, K.A., & Thomas, K.A. (1995) Purification and characterization of a naturally occurring vascular endothelial growth factor. Placenta growth factor heterodimer. *J.Biol.Chem*., Vol.270, No.13, (March 1995), pp. 7717-7723, ISSN 0021-

Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. *Dev. Dyn*., Vol.203,

*of the Kidney*, eigth edition, R.W. Schrier, (Ed.), 502-539, Lippincott, Williams &

in the diagnosis of polycystic kidney disease. *J.Urol*., Vol.102, No.2,(August 1969),

encodes a 14kb transcript and lies within a duplicated region of chromosome. 16.

Joplin, R.E., Okolicsanyi, L. & Strazzabosco, M. (2006) Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases.

Progression of autosomal-dominant polycystic kidney disease in children. *Kidney* 

inflammation. *Trends Immunol.,* Vol.27, No.12, ( December 2006) pp. 552-558, ISSN

variation in autosomal dominant polycystic kidney disease. *Am. J. Kidney Dis.,* Vol.

kidney disease. *Clin. Hemorheol. Microcirc*., Vol.38, No.3, (2008), pp. 201-207, ISSN

Jones, R.H. (1992). Factors affecting the progression of renal disease in autosomaldominant polycystic kidney disease. *Kidney Int.,* Vol.41, No.6, (November 1992) pp.

*Proc Natl Acad Sci U S A*., Vol.98, No. 3, (January 2001), pp. 790-792, ISSN 0027-8424

Chmielewski, M., Heimbürger, O., Stenvinkel, P., Lindholm, B. & Axelsson. J. (2009) Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular


Augustin, H.G., Koh, G.Y., Thurston, G. & Alitalo, K. (2009) Control of vascular

Bevan, H.S., van den Akker, N.M., Qiu, Y., Polman, J.A., Foster, R.R., Yem, J., Nishikawa, A.,

Boletta, A. (2009) Emerging evidence of a link between polycystins and the mTOR pathways. *PathoGenetics*, Vol.2, No.1, October 2009, pp. 6, ISSN1755-8417 Brodsky, K.S., McWilliams, R.R., Amura, C.R., Barry, N.P. & Doctor, R.B. (2009) Liver cyst

*(Maywood),* Vol.234, No.10 (October 2009), pp. 1155-1165, ISSN 1535-3702 Chade, A.R., Zhu, X., Mushin, O.P., Napoli, C., Lerman, A. & Lerman, L.O.(2006)

Chapin, H.C. & Caplan, M.J. (2010). The cell biology of polycystic kidney disease. *J. Cell Biol.*,

Chapman, A.B., Johnson, A.M., Rainguet, S., Hossack, K., Gabow, P. & Schrier, R.W. (1997)

*Am. Soc. Nephrol*., Vol.8, No.8, (August 1997), pp. 1292-1297, ISSN 1046-6673 Chapman. A.B., Guay-Woodford, L.M., Grantham, J.J., Torres, V.E., Bae, K.T., Baumgarten,

Chung, A.S., Lee, J. & Ferrera, N. (2010) Targeting the tumour vascalture: insights from

Cornell, S.H. (1970) Angiography in polycystic disease of the kidneys. *J.Urol.,* Vol.103, No.3,

David, S., Kumpers, P., Hellpap, J., Horn, R., Leitolf, H., Haller, H. & Kielstein, J.T. (2009)

*Am J Kidney Dis.,* Vol.53, No.5, (May 2009), pp. 770-778, ISSN 0272-6386 Di Marco, G.S., Reuter, S., Hillebrand, U., Amler, S., Konig, M., Larger, E., Oberleithner, H.,

Vol. 191, No. 4, (November 2010), pp. 701-710, ISSN 0021-9525

No.3, (September 2003), pp. 1035-1045, ISSN 0085-2538

(July 1970), pp. 24-26, ISSN 0970-1591

(October 2009), pp. 2235-2245, ISSN 1046-6673

*Mol. Cell. Biol*., Vol.10, No.3, (March 2009), pp. 165-177, ISSN 1471-0072 Bello-Reuss, E., Holubec, K. & Rajaraman S. (2001). Angiogenesis in autosomal-dominant

(February 2005), pp. 337-341, ISSN 0039-2499

0085-2538

ISSN 1660-2137

0892 6638

ISSN1474-175X

receptor-alpha in a rodent experimental stroke model. *Stroke,* Vol.36, No.2,

morphogenesis and homeostasis through the angiopoietin-Tie system. *Nat. Rev.* 

polycystic kidney disease. *Kidney Int.,* Vol. 60, No. 1, (July 2001), pp. 37-45, ISSN

Satchell, S.C., Harper, S.J., Gittenberger-de Groot, A.C. & Bates, D.O. (2008) The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development. *Nephron Physiol*., Vol.110, No.4, (November 2008),pp. 57-67,

cytokines promote endothelial cell proliferation and development. *Exp. Biol. Med.* 

Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia. *Faseb. J.,* Vol.20, No.10, (August 2006), pp. 1706-1708, ISSN

Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. *J.* 

D.A., Kenney, P.J., King, B.F., Jr., Glockner, J.F., Wetzel, L.H., Brummer, M.E., O'Neill, W.C., Robbin, M.L., Bennett, W.M., Klahr, S., Hirschman, G.H., Kimmel, P.L., Thompson, P.A. & Miller, J.P. (2003). Renal structure in early autosomaldominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. *Kidney Int.,* Vol.64,

physiological angiogenesis. *Nat. Cancer Rev*., Vol.10, No.7, (July 2010), pp. 505-514,

Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.

Brand, E., Pavenstadt, H. & Brand, M. (2009) The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD. *J. Am. Soc. Nephrol.,* Vol.20, No.10,


disease and survival in prevalent haemodialysis patients. *Nephrol. Dial. Transplant,* Vol.24, No.11, (November 2009), pp. 3468-3473, ISSN 0931-0509

Angiogenesis and the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease 107

Konoshita, T., Okamoto, K., Koni, I. & Mabuchi, H. (1998). Clinical characteristics of

Lim, H.S., Lip, G.Y. & Blann, A.D. (2005) Angiopoietin-1 and angiopoietin-2 in diabetes

*Acad. Sci.,* Vol.99, No.17, (May 2002), pp. 11205-11210, ISSN 0027-8424 Lovegrove, F.E., Tangpukdee, N., Opoka, R.O., Lafferty, E.I., Rajwans, N., Hawkes, M.,

Maeshima, Y. & Makino, H. (2010) Angiogenesis and chronic kidney disease. Fibrogenesis and Tissue Repair, online Vol.3, No.13, (online August 5, 2010), ISSN 1755-1536 Makinde, T. & Agarwal, D.K. (2008) Intra and extravascular transmembrane signaling of

Mirmohammadsadegh, A., Marini, A., Nambiar, S., Hassan, M., Tannapfel, A., Ruzicka, T.,

Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S.L., Veldhuisen, B., Saris, J.J., Reynolds,

Mu, W., Long, D.A., Ouyang, X., Agarwal, A., Cruz, W.E., Roncal, C.A., Nakagawa, T., Yu,

Na, X., Wu, G,, Ryan, C.K., Schoen, S.R., di'Santagnese, P.A. & Messing, E.M. (2003)

Nadar, S.K., Blann, A.D. & Lip, G.Y. (2004) Plasma and platelet-derived vascular endothelial

*Res,* Vol.66, No. 3, (July 2006) pp. 6546-6552, ISSN 0969-6970

(March 2009), pp. e4912, ISSN 1932-6203

2008), pp. 810-828, ISSN 1582-1838

1339-1342, ISSN 0036-8075

F152, ISSN 0363-6127

588-592, ISSN 0970-1591

(October 2005), pp. 336-343, ISSN 0954-6820

0301-0430

polycystic kidney disease with end-stage renal disease. The Kanazawa Renal Disease Study Group. *Clin. Nephrol.,* Vol.50, No.2, (August 1998), pp. 113-117, ISSN

mellitus: relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. *Atherosclerosis,* Vol.180, No.1 (May 2005) pp.113-118, ISSN Lobov, I.B., Brooks, P.C. & Lang, R.A. (2002) Angiopoietin-2 displays VEGF-dependent

modulation of capillary structure and endothelial cell survival in vivo. *Proc. Natl.* 

Krudsood, S., Looareesuwan, S., John, C.C., Liles, C. & Kain, K.C. (2009) Serum Angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. *PlosOne,* Vol.4, No.3,

angiopoietin-1-Tie-2 receptor in health and disease. *J. Cell. Med*., Vol.12, No.3, (June

& Hengge, U.R. (2006) Epigenetic silencing of the PTEN gene in melanoma. *Cancer* 

D.M., Cai, Y., Gabow, P.A., Pierides, A., Kimberling, W.J., Breuning, M.H., Deltas, C.C., Peters, D.J. & Somlo, S. (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. *Science*, Vol.272, No.5266, (May 1996), pp.

X., Hauswith, W.W. & Johnson, R.J. (2009) Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. *Am. J. Physiol. Renal Physiol*., Vol.296, No.1, (January 2009), pp. F145-

Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. *J. Urol.,* Vol.170, No.2.pt1, (August 2003), pp.

growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy. *J. Intern. Med.,* Vol.256, No.4, (October 2004), pp. 331-337, ISSN 0954-6820 Nadar, S.K., Blann, A., Beevers ,D.G. & Lip, G.Y. (2005) Abnormal angiopoietins 1&2,

angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. *J Intern Med*., Vol.258, No 4,


Hakroush, S., Moeller, M.J., Thelig, F., Kaissling, B., Sijmonsma, T.P., Jugold, M., Akeson,

Heshmat, N.M. & El-Kerdany, T.H. (2007) Serum levels of vascular endothelial growth

Holash, J., Maisonpierre, P.C., Compton, D., Boland, P., Alexander, C.R., Zagzag, D.,

Iliescu, R., Fernandez, S.R., Kelsen, S., Maric, C. & Chade, A.R (2009) Role of renal

Ichinose, K., Maeshima, Y., Yamamoto, Y., Kitayama, H., Takazawa, Y., Hirokoshi, K.,

Karapanen, T, Bry, M., Ollila, H.M., Seppänen-Laasko, T, Liimatta, H., Kivelä, R., Helkamaa,

Kitamoto, Y., Takeya, M., Tokunaga, T. & Tomita,Y. (2001) Glomerular endothelial cells are

*Exp. Med.*, Vol.195, No.1, (September 2001), pp. 43-54, ISSN 0040-8727 Kitayama, H., Maeshima, Y., Takazawa, Y.,Yamamoto, Y., Wu, Y., Ichinose, K., Hirokoshi,

*Allergy Immunol.,* Vol.18 No.4, (June 2007), pp. 346-353, ISSN 0905-6157 Hoeben, A., Landuyt, B., Highley, H.W., Van Oosterom, A.T. & DeBruijn, E.A. (2004)

Vol.24, No.11, (November 2009), pp. 3468-3473, ISSN 0931-0509

(November 2009), pp. 1883-1895, ISSN 0002-9440

(December 2004,) pp. 549-580, ISSN 0031-6997

Vol. 25, No.4, (April 2004), pp.1079-1087, ISSN 0931-0509

Vol.55, No.5, (May 2006), pp. 1232-1242, ISSN 0012-1797

1999( 1994-1998, ISSN 0036-8075

1026, ISSN 0009-7330

pp. 169-183, ISSN 0939-4451

disease and survival in prevalent haemodialysis patients. *Nephrol. Dial. Transplant,*

A.L., Traykova-Brauch, M., Hosser, H., Hähnel, B., Koesters, R. & Kriz, W. (2009) Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. *Am. J. Pathol*., Vol.175, No.5,

factor in children and adolescents with sytemic lupus erythematosus. *Pediatr.* 

Vascular endothelial growth factor and angiogenesis. *Pharmacol. Rev*., Vol.56,

Yancopoulos, G.D. & Wiegand, S.J. (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. *Science*, Vol.284, No.5422, (June

microcirculation in experimental renovascular disease. *Nephrol. Dial.Transplant.*,

Sugiyama, H., Yamasaki, Y. & Eguchi, K. (2005) Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. *Diabetes*, Vol.54, No.10, (October 2005), pp. 2891-2903, ISSN 0012-1797 Ichinose, K., Maeshima, Y., Yamamoto, Y., Kinomura, M., Hirokoshi, K., Kitayama, H.,

Takazawa, Y., Sugiyama, H., Yamasaki, Y. Agata, N, & Makino, H. (2006) 2-(8 hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) proprionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice. *Diabetes*,

T., Merentie, M., Jeltsch, M., Paavonen, K., Andersson, L.C., Mervaala, E., Hassinen, I.E., Ylä-Herttuala, S., Oresic, M., & Alitalo, K. (2008) Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. *Circ.Res*., Vol.103, No.9, (October 2008), pp. 1018-

maintained by vascular endothelial growth factor in the adult kidney. *Tohoku, J.* 

K., Sugiyama, H., Yamasaki, Y. & Makino, H. (2006) Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. *Am. J. Hyperens*., Vol.19, No.7, (July 2006), pp. 718-727, ISSN 0895-7061 Koch, S., Tugues, S., LI, X., Gualandi, L. & Claesson-Welsh, L. (2011) Signal transduction by

vascular endothelial growth factor receptors. *Biochem. J*., Vol.437, No.2, (July 2011),


Angiogenesis and the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease 109

Saito, T., Yamamoto, Y., Matsumura, T., Fujimura, H. & Shinno, S. (2009) Serum levels of

Schrier, R.W. (2006) Optimal care of autosomal dominant polycystic kidney disease patients.

Seeman, T., Dusek, J., Vondrichova, H., Kyncl, M., John, U., Misselwitz, J. & Janda, J. (2003).

Shillingford, J.M., Murcia, N.S., Larson, C.H., Low, S.H., Hedgepeth, R., Brown, N., Flask,

Song, X., DiGiovanni, V., He, N., Wang, K., Ingram, A., Rosenblum, N.D. & Pei, Y. (2009)

Sugimoto, H, Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A. & Kalluri,

*Biol. Chem*., Vol.278, No.15, (April 2003), pp. 12605-12608, ISSN 0021-9258 Tam, K.F., Liu, V.W., Liu, S.S., Tsang, P.C., Cheung, A.N., Yip, A.M. & Ngan, H.Y. (2007)

*Res. Clin. Oncol.,* Vol.133, No.5, (May 2007), pp. 331-341, ISSN 0171-5216 Tao, Y., Kim, J., Yin, Y., Zafar, I., Falk, S., He, Z., Faubel, S., Schrier, R.W. & Edelstein, C.L.

Thomas, S., Vanuystel, J., Gruden, G., Rodríguez, V., Burt, D., Gnudi, L., Hartley, B.&

Torres Filho I.P., Leunig, M.,Yuan, F., Intagletta, M. & Jain R.K. (1994) Noninvasive

*Nephrology* Vol.11, No.2, (April 2006), pp.124-130, ISSN 1320-5358

Vol 8, No.3, (June 2003), pp. 107-110, ISSN 1359-5237

(February 1995), pp. F240-F250, ISSN 0363-6127

*Brain Dev.,* Vol.31, No.8, (September 2009), pp. 612-617, ISSN 0387-7604 Satchell, S.C., Anderson, K.L. & Mathieson, P.W. (2004) Angiopoietin 1 and vascular

6673

ISSN 0964-6906

(July 2000), ISSN 1046-6673

0027-8424

vascular endothelial growth factor elevated in patients with muscular dystrophy.

endothelial growth factor modulate human glomerular endothelial cell barrier properties. *J. Am. Soc. Nephrol*., Vol.15, No.3, (March 2004), pp.566-574, ISSN1046-

Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease. *Blood Press. Monit.,* 

C.A., Novick, A.C., Goldfarb, D.A., Kramer-Zucker, A., Walz, G., Piontek, K.B., Germino, G.G. & Weimbs, T. (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease, *Proc. Natl. Acad. Sci. USA*., Vol.103, No.14, (April 2006), pp. 5466-5471, ISSN 0027-8424 Simon, M., Grone, H.J., Johren, O., Kullmer, J., Plate, K.H., Risau, W. & Fuchs, E. (1995)

Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. *Am. J. Physiol. Renal Physiol*., Vol.268, No.2 pt. 2,

Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. *Hum. Mol. Genet*., Vol.18, No.13, (July 2009), pp.2328-2343,

R. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEG antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria*. J.* 

Methylation profile in benign, borderline and malignant ovarian tumors. *J. Cancer* 

(2007) VEGF receptor inhibition slows the progression of polycycstic kidney diesease. *Kidney Int.,* Vol.72, No.11, (December 2007), pp.1358-1366, ISSN 0085-2538

Viberti, G. (2000) Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. *J. Am. Soc.Nephrol*., Vol.11, No.7,

measurement of microvascular interstitial oxygen profiles in human tumor SCID mice. *Proc Natl Acad Sci U S A*., Vol.91, No 6, (March 1994), pp. 2081-2085, ISSN


Nasu, T., Maeshima Y, Kinomura, M., Hirokoshi-Kawahara, K, Tanabe, K., Sugiyama, H.,

Nichols, M.T., Gidey, E., Matzakos, T., Dahl, R., Stiegmann, G., Shah, R.J., Grantham, J.J.,

Obermüller, N., Morente, N., Kränzlin, B., Gretz, N. & Witzgall, R. (2001) A possible role for

Ohgaki, H. & Kleihues, P. (2007) Genetic pathways to primary and secondary glioblastoma. *Am. J. Pathol.,* Vol.170, No.5 (May 2007), pp. 1445-1453, ISSN 0002-9440 Ortega, N., Hutchings, H. & Plouët, J. (1999) Signal relays in the VEGF system. *Front. Biosci*.,

Otrock, Z.K., Mahfouz, R.A., Makarem, J.A. & Shamseddine, A.I. (2007) Understanding the

Park, J.H., Park, K.J., Kim, Y.S., Sheen, S.S., Lee, K.S., Lee, H.N., Oh, Y.J. & Heang, S.C. (2007)

Park, J., Choi, H., Kim, Y., Kim, Y., Sheen, S., Choi, J., Lee, H., Lee, K., Chung, W., Lee, S.,

Pei, Y. (2011) Practical genetics for autosomal dominant polycystic kidney disease. *Nephron Clin. Pract*., Vol.118, No.1, (January 2011), pp. c19-c30, ISSN 1660-8151 Persson, A.B. & Buschmann, I.R. (2011) Vascular growth in health and disease. *Front. Mol.* 

Pugh, C.W. & Ratcliffe PJ. (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. *Nat Med.* Vol.9, No.6, (June 2003), pp. 677-684, ISSN 1340-3443 Reed, B.Y., Masoumi, A., Elhassan, E., McFann, K., Cadnapaphornchai, M. & Schrier,

Robert, B., Zhao, X. & Abrahamson, D.R. (2000) Coexpression of neuropilin-1, Flk1, and

Renal Physiol., Vol.279, No.2, (August 2000), pp. F275-282, ISSN 0363-6127 Rosner, M., Hanneder, M., Siegel, N., Valli, A., Fuchs, C. & Hengstschläger, M. (2008) The

Rudnicki, M., Perco, P., Enrich, J., Eder, S., Heininger, D., Bernthaler, A., Sarközi, R.,

*Invest.,* Vol.89, No.3, (January 2009), pp. 337-346, ISSN 0023-6837

No.4, (October 2004), pp. 836-846, ISSN 1386-6346

280, No.3, (March 2001), pp. F540-F550, ISSN 0363-6127

Vol.4, (February 1999), pp. D141-D152, ISSN 1093-9946

*Neurosci*., Vol.14, Epub., August 2011, ISSN 0892-6638

(September – October), pp. 284-292, ISSN 1383-5718

(July 2007), pp. 200-206, ISSN 0012-3692

2009), pp. 359-364, ISSN 0169-5002

128-134, ISSN 0272-6386

0012-1797

1079-9796

Sonoda, H., Sato, Y. & Makino, H. (2009) Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. *Diabetes*, Vol.58, No.10, (October 2009), pp. 2365-2375, ISSN

Fitz, J.G. & Doctor, R.B. (2004) Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. *Hepatology,* Vol.40,

metalloproteinaases in renal cyst development. *Am. J. Physiol. Renal Physiol*., Vol.

biology of angiogenesis: review of the most important molecular mechanisms. *Blood Cells Mol. Dis.,* Vol*.*39, No.2, (September-October 2007), pp. 212-220, ISSN

Serum angiopoietin-2 as a clinical marker for lung cancer. *Chest,* Vol.132, No.1,

Park, K., Hwang, S., Lee, K. & Park, K. (2009) Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer. *Lung Cancer,* Vol.66, No.1-2, (December

R.W.(2011) Angiogenic growth factors in young patients with autosomal dominant polycystic kidney disease. *Am. J. Kidney Disease*, Vol.79, No.1, (January 2011), pp.

VEGF(164) in developing and mature mouse kidney glomeruli. Am. J. Physiol.

mTOR pathway and its role in human genetic diseases. *Mut. Res*., Vol.659, No.3,

Noppert, S.J., Schramek, H., Mayer, B., Oberbauer, R. & Mayer, G. (2009) *Lab.* 


Torres, V.E., King, B.F., Chapman, A.B., Brummer, M.E., Bae, K.T., Glockner, J.F., Arya, K., Risk, D., Felmlee, J.P., Grantham, J,J., Guay-Woodford, L.M., Bennett, W.M., Klahr, S., Meyers, C.M., Zhang, X., Thompson, P.A.& Miller, J.P. (2007) Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. *Clin. J. Am. Soc. Nephrol.,* Vol.2, No.1, (January 2007), pp. 112-120, ISSN 1555-9041

**Part 3** 

**The Renin-Angiotensin-Aldosterone Pathway** 

